Literature DB >> 10733217

Changes of alpha1-acid glycoprotein microheterogeneity in acute inflammation stages analyzed by isoelectric focusing using serum obtained postoperatively.

S Iijima1, K Shiba, M Kimura, K Nagai, T Iwai.   

Abstract

The relationship between variations of alpha1-acid glycoprotein (orosomucoid, AGP) microheterogeneity detected from isoelectric focusing (IEF) patterns and clinical stage of acute inflammation based on serum C-reactive protein (CRP) levels and interleukin-6 (IL-6) levels was investigated. Serum samples were obtained from healthy subjects, and from patients with esophageal or stomach carcinoma before and after operation. Samples without neuraminidase treatment were used for AGP microheterogeneity analysis, and samples with neuraminidase treatment for AGP heterogeneity analysis. In AGP microheterogeneity, nine bands were detected in the range of pI 3.18-3.57 in sera obtained from healthy subjects. In patients, AGP microheterogeneity changed the first day after operation; the percentage of bands surrounding pI 3.5 increased, and the highest value appeared in sera taken the first or second day after operation and then decreased quickly. These bands showed reactivity for concanavalin A (Con A). The increase in Con A-reactive AGP occurred later than the increase in IL-6, and occurred earlier than the increase in CRP. On the seventh day after operation, the percentage of bands around pI 3.2 increased. These bands showed the reactivity for Datura stramonium agglutinin. On the other hand, in samples with neuraminidase treatment, little change of AGP heterogeneity was observed in most samples, which did not reflect the stage of inflammation. These findings suggested that AGP microheterogeneity detection was a useful marker for the clinical stage of inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733217     DOI: 10.1002/(SICI)1522-2683(20000301)21:4<753::AID-ELPS753>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

1.  Urinary protein analysis in pre- and postoperative cancer patients.

Authors:  Kayo Yokomizo; Shiro Iijima; Nobue Sakai; Yuriko Kurihara; Nobuo Hitratsuka; Kagami Nagai; Takehisa Iwai; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 2.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

Review 3.  Recent advances in sialic acid-focused glycomics.

Authors:  Huan Nie; Yu Li; Xue-Long Sun
Journal:  J Proteomics       Date:  2012-04-05       Impact factor: 4.044

4.  An improved protocol for N-glycosylation analysis of gel-separated sialylated glycoproteins by MALDI-TOF/TOF.

Authors:  Piliang Hao; Yan Ren; Yongming Xie
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

5.  Enrichment of glycoproteins using nanoscale chelating concanavalin A monolithic capillary chromatography.

Authors:  Shun Feng; Na Yang; Subramaniam Pennathur; Steve Goodison; David M Lubman
Journal:  Anal Chem       Date:  2009-05-15       Impact factor: 6.986

6.  Exploiting lectin affinity chromatography in clinical diagnosis.

Authors:  P R Satish; A Surolia
Journal:  J Biochem Biophys Methods       Date:  2001-10-30

7.  Structural basis for substrate specificity of mammalian neuraminidases.

Authors:  Victoria Smutova; Amgad Albohy; Xuefang Pan; Elena Korchagina; Taeko Miyagi; Nicolai Bovin; Christopher W Cairo; Alexey V Pshezhetsky
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

Review 8.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.